Bancel Stephane's Form 4 filing
Moderna, Inc. (MRNA) · filed Apr 22, 2022
- Accession no.
- 0001127602-22-012407
- Filed
- Apr 22, 2022
- Trade date
- Apr 20-21, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions. Open-market sales total $2.85M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bancel StephaneCIK 0001443340 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 20, 2022 | Common Stock | SSaleDisposed | −429 | $148.02F2 | −$63,500.58 | 5,443,106 | Direct | |
| Apr 20, 2022 | Common Stock | SSaleDisposed | −538 | $149.28F3 | −$80,312.64 | 5,442,568 | Direct | |
| Apr 20, 2022 | Common Stock | SSaleDisposed | −4,003 | $150.13F4 | −$600,970.39 | 5,438,565 | Direct | |
| Apr 20, 2022 | Common Stock | SSaleDisposed | −2,768 | $151.10F5 | −$418,244.8 | 5,435,797 | Direct | |
| Apr 20, 2022 | Common Stock | SSaleDisposed | −1,262 | $152.34F6 | −$192,253.08 | 5,434,535 | Direct | |
| Apr 20, 2022 | Common Stock | GGiftDisposed | −4,000 | –F8 | – | 5,430,535 | Direct | |
| Apr 21, 2022 | Common Stock | SSaleDisposed | −10,000 | $149.43 | −$1,494,300 | 6,924,880 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $147.60 to $148.53. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $148.64 to $149.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $149.67 to $150.66. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.68 to $151.66. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.79 to $152.76. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F8
The reported disposition represents a bona fide charitable gift made by the reporting person.
Referenced by the price of 1 transaction in Table I.